Titans Of Pharma: J&J Back On Top For CEO Remuneration
Lilly And Novo Nordisk Highlight US/Europe Divergence
J&J topped the league table for CEO pay in 2023, a position it has held for three of the four past years. Meanwhile, the two companies that arguably generated the most buzz in 2023 neatly depict the stark contrast between the US and Europe when it comes to executive remuneration.
